These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 12012451)
1. Density functional theory and surface enhanced Raman spectroscopy characterization of novel platinum drugs. Giese B; Deacon GB; Kuduk-Jaworska J; McNaughton D Biopolymers; 2002; 67(4-5):294-7. PubMed ID: 12012451 [TBL] [Abstract][Full Text] [Related]
2. Interaction of anticancer drug cisplatin with guanine: density functional theory and surface-enhanced Raman spectroscopy study. Giese B; McNaughton D Biopolymers; 2003; 72(6):472-89. PubMed ID: 14587070 [TBL] [Abstract][Full Text] [Related]
3. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study. Deubel DV J Am Chem Soc; 2006 Feb; 128(5):1654-63. PubMed ID: 16448139 [TBL] [Abstract][Full Text] [Related]
4. Formation of carbonato and hydroxo complexes in the reaction of platinum anticancer drugs with carbonate. Di Pasqua AJ; Centerwall CR; Kerwood DJ; Dabrowiak JC Inorg Chem; 2009 Feb; 48(3):1192-7. PubMed ID: 19113934 [TBL] [Abstract][Full Text] [Related]
5. EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate. Bouvet D; Michalowicz A; Crauste-Manciet S; Brossard D; Provost K Inorg Chem; 2006 Apr; 45(8):3393-8. PubMed ID: 16602799 [TBL] [Abstract][Full Text] [Related]
7. The gas-phase chemistry of cis-diammineplatinum(II) complexes: a joint experimental and theoretical study. Springer A; Bürgel C; Böhrsch V; Mitrić R; Bonacić-Koutecký V; Linscheid MW Chemphyschem; 2006 Aug; 7(8):1779-85. PubMed ID: 16847840 [TBL] [Abstract][Full Text] [Related]
8. Conformational and vibrational study of platinum(II) anticancer drugs: cis-diamminedichloro-platinum(II) as a case study. Amado AM; Fiuza SM; Marques MP; Batista de Carvalho LA J Chem Phys; 2007 Nov; 127(18):185104. PubMed ID: 18020667 [TBL] [Abstract][Full Text] [Related]
9. Electrospray ionization tandem mass spectrometric studies of competitive pyridine loss from platinum(II) ethylenediamine complexes by the kinetic method. Holmes RJ; O'Hair RA; McFadyen WD Rapid Commun Mass Spectrom; 2000; 14(24):2385-92. PubMed ID: 11114055 [TBL] [Abstract][Full Text] [Related]
10. Bioactive fragments synergically involved in the design of new generation Pt(ii) and Pd(ii)-based anticancer compounds. Pucci D; Bellusci A; Bernardini S; Bloise R; Crispini A; Federici G; Liguori P; Lucas MF; Russo N; Valentini A Dalton Trans; 2008 Nov; (43):5897-904. PubMed ID: 19082045 [TBL] [Abstract][Full Text] [Related]
11. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of the interactions of cisplatin and carboplatin with nucleotides using UV resonance Raman spectroscopy. Benson RL; Gustafson TL Biopolymers; 1993 Nov; 33(11):1631-41. PubMed ID: 8241424 [TBL] [Abstract][Full Text] [Related]
13. Density functional theory characterization and descriptive analysis of cisplatin and related compounds. Dans PD; Coitiño EL J Chem Inf Model; 2009 Jun; 49(6):1407-19. PubMed ID: 19463014 [TBL] [Abstract][Full Text] [Related]
14. Raman, surface enhanced Raman spectroscopy, and DFT calculations: a powerful approach for the identification and characterization of 5-fluorouracil anticarcinogenic drug species. Pavel I; Cota S; Cînta-Pînzaru S; Kiefer W J Phys Chem A; 2005 Nov; 109(44):9945-52. PubMed ID: 16838911 [TBL] [Abstract][Full Text] [Related]
15. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents. Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657 [TBL] [Abstract][Full Text] [Related]
16. Inelastic neutron scattering study of Pt(II) complexes displaying anticancer properties. de Carvalho LA; Marques MP; Martin C; Parker SF; Tomkinson J Chemphyschem; 2011 May; 12(7):1334-41. PubMed ID: 21523878 [TBL] [Abstract][Full Text] [Related]
17. The kinetics and mechanisms of the reaction of Mesna with cisplatin, oxiplatin and carboplatin. Oprea A; Bazzazi H; Kangarloo B; Wolff JE Anticancer Res; 2001; 21(2A):1225-9. PubMed ID: 11396168 [TBL] [Abstract][Full Text] [Related]
18. Characterization of surface water on Au core Pt-group metal shell nanoparticles coated electrodes by surface-enhanced Raman spectroscopy. Jiang YX; Li JF; Wu DY; Yang ZL; Ren B; Hu JW; Chow YL; Tian ZQ Chem Commun (Camb); 2007 Nov; (44):4608-10. PubMed ID: 17989807 [TBL] [Abstract][Full Text] [Related]
19. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP. Pantoja E; Gallipoli A; van Zutphen S; Komeda S; Reddy D; Jaganyi D; Lutz M; Tooke DM; Spek AL; Navarro-Ranninger C; Reedijk J J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978 [TBL] [Abstract][Full Text] [Related]
20. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes. Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]